Dr. Dennis Liotta has been selected as the recipient of the 2022 Perkin Medal.Continue readingDennis Liotta receives Perkin Medal
Categories
Dr. Dennis Liotta has been selected as the recipient of the 2022 Perkin Medal.Continue readingDennis Liotta receives Perkin Medal
Molnupiravir is currently being developed by Merck & Co. Inc. in collaboration with Ridgeback Biotherapeutics, which licensed the drug from DRIVE (founded by Emory chemist Dennis Liotta) in 2020. It could be the first oral antiviral medicine to treat COVID-19. Continue readingMolnupiravir and Drug Development at Emory
DRIVE seeks disease-fighting solutions via a different paradigm than big pharmaceutical industry. The New York Times features an opinion piece titled “In the Race for a Covid-19 Pill, a Little Lab Plays a Big Role.”Continue readingLiotta Group and DRIVE featured in New York Times